Quick Answer
Cardlytics, Inc. reported Total Revenue of $233.27 million for the year ending 2025.
- Cardlytics, Inc. showed a decrease of -16.2% in Total Revenue from 2024 to 2025.
- This data is from Cardlytics, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $26.88 million | Q2 2017: $32.81 million | Q3 2017: $31.41 million | Q1 2018: $32.71 million | Q2 2018: $35.57 million | Q3 2018: $34.58 million | Q1 2019: $35.99 million | Q2 2019: $48.73 million | Q3 2019: $56.42 million | Q1 2020: $45.51 million | Q2 2020: $28.22 million | Q3 2020: $46.08 million | Q1 2021: $53.23 million | Q2 2021: $58.85 million | Q3 2021: $64.98 million | Q1 2022: $67.93 million | Q2 2022: $75.41 million | Q3 2022: $72.71 million | Q1 2023: $64.33 million | Q2 2023: $76.70 million | Q3 2023: $79.01 million | Q1 2024: $67.61 million | Q2 2024: $69.64 million | Q3 2024: $67.06 million | Q1 2025: $61.90 million | Q2 2025: $63.25 million | Q3 2025: $52.03 million.
- Over the full 10 years of available data (2016 to 2025), Cardlytics, Inc.'s Total Revenue has grown by 106.8%.
- Historical annual values: Fiscal year 2025: $233.27 million | Fiscal year 2024: $278.30 million | Fiscal year 2023: $309.20 million | Fiscal year 2022: $298.54 million | Fiscal year 2021: $267.12 million | Fiscal year 2020: $186.89 million | Fiscal year 2019: $210.43 million | Fiscal year 2018: $150.68 million | Fiscal year 2017: $130.37 million | Fiscal year 2016: $112.82 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: